BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31362125)

  • 1. Survival outcomes of ovarian cancer patients treated with secondary cytoreductive surgery for isolated lymph node recurrence: A systematic review of the literature.
    Pergialiotis V; Androutsou A; Papoutsi E; Bellos I; Thomakos N; Haidopoulos D; Rodolakis A
    Int J Surg; 2019 Sep; 69():61-66. PubMed ID: 31362125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status.
    Gallotta V; Bruno M; Conte C; Giudice MT; Davià F; Moro F; Zannoni GF; Fagotti A; De Bonis M; Capoluongo E; Scambia G; Ferrandina G
    Eur J Surg Oncol; 2020 Jul; 46(7):1327-1333. PubMed ID: 32085925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study.
    Lopes A; Rangel Costa RL; di Paula R; Anton C; Calheiros Y; Sartorelli V; Kanashiro YM; de Lima JA; Yamada A; Pinto GLS; Vianna MR; Nogueira Dias Genta ML; Ribeiro U; Dos Santos MO
    Int J Gynecol Cancer; 2019 Jan; 29(1):188-194. PubMed ID: 30640703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: a multicenter study.
    Ferrero A; Ditto A; Giorda G; Gadducci A; Greggi S; Daniele A; Fuso L; Panuccio E; Scaffa C; Raspagliesi F; Sismondi P; Biglia N
    Eur J Surg Oncol; 2014 Jul; 40(7):891-8. PubMed ID: 24378007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors.
    Blanchard P; Plantade A; Pagès C; Afchain P; Louvet C; Tournigand C; de Gramont A
    Gynecol Oncol; 2007 Jan; 104(1):41-5. PubMed ID: 16952391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated lymph node recurrence in epithelial ovarian cancer: Recurrence with better prognosis?
    Delangle R; Rossard L; Cirier J; Delvallée J; Bendifallah S; Touboul C; Collinet P; Coutant C; Akladios C; Lavoué V; Bolze PA; Huchon C; Bricou A; Canlorbe G; Ballester M; Darai E; Body G; Ouldamer L;
    Eur J Obstet Gynecol Reprod Biol; 2020 Jun; 249():64-69. PubMed ID: 32381349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
    Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
    Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome.
    Legge F; Petrillo M; Adamo V; Pisconti S; Scambia G; Ferrandina G
    BMC Cancer; 2008 Dec; 8():367. PubMed ID: 19077269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Surgical Strategies in the Treatment of Gynecological Malignancies.
    Angeles MA; Martínez-Gómez C; Migliorelli F; Voglimacci M; Figurelli J; Motton S; Tanguy Le Gac Y; Ferron G; Martinez A
    Curr Treat Options Oncol; 2018 Nov; 19(12):73. PubMed ID: 30411170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The addition of lymphadenectomy to secondary cytoreductive surgery in comparison with bulky node resection in patients with recurrent ovarian cancer.
    Bogani G; Leone Roberti Maggiore U; Chiappa V; Ditto A; Martinelli F; Sabatucci I; Mosca L; Lorusso D; Raspagliesi F
    Int J Gynaecol Obstet; 2018 Dec; 143(3):319-324. PubMed ID: 30194778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic Management of Ovarian Cancer Patients With Localized Carcinomatosis and Lymph Node Metastases: Results of a Retrospective Multi-institutional Series.
    Gallotta V; Ghezzi F; Vizza E; Fagotti A; Ceccaroni M; Fanfani F; Chiantera V; Ercoli A; Rossitto C; Conte C; Uccella S; Corrado G; Scambia G; Ferrandina G
    J Minim Invasive Gynecol; 2016; 23(4):590-6. PubMed ID: 26872630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tertiary Cytoreduction for Isolated Lymphnode Recurrence (ILNR) Ovarian Cancer in a BRCA2 Mutated Patient: Our Experience and Prevalence of BRCA 1 or 2 Genes Mutational Status in ILNR.
    Bruno M; Ludovisi M; Ronsini C; Capanna G; Stabile G; Guido M
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery.
    Benedetti Panici P; Perniola G; Angioli R; Zullo MA; Manci N; Palaia I; Bellati F; Plotti F; Calcagno M; Basile S
    Int J Gynecol Cancer; 2007; 17(6):1245-51. PubMed ID: 17425680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node-positive stage IIIC ovarian cancer: a separate entity?
    Berek JS
    Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S18-20. PubMed ID: 19955908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
    Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE
    Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lumboaortic and iliac lymphadenectomy for lymph node recurrence of colorectal cancer: prognostic value of the MSI phenotype.
    Lefevre JH; Rondelli F; Mourra N; Bennis M; Tiret E; Parc R; Parc Y
    Ann Surg Oncol; 2008 Sep; 15(9):2433-8. PubMed ID: 18566862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis.
    Paik ES; Shim M; Choi HJ; Lee YY; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
    Gynecol Oncol; 2016 Nov; 143(2):252-257. PubMed ID: 27567053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer.
    Felsinger M; Minar L; Weinberger V; Rovny I; Zlamal F; Bienertova-Vasku J
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():154-160. PubMed ID: 29957400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and patterns of secondary relapse in platinum-sensitive ovarian cancer: implications for tertiary cytoreductive surgery.
    Tang J; Liu DL; Shu S; Tian WJ; Liu Y; Zang RY
    Eur J Surg Oncol; 2013 Jul; 39(7):786-91. PubMed ID: 23490332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.